Newsmeme!
Discover News you didn't know existed
Lancet Window
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Efficacy Of Tecarfarin Mirrors Earlier Studies While Primary Endpoint Missed
Published July 9, 2009, 5:14 am, Medical News Today
ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced results from its Phase 2/3 clinical trial, EmbraceAC, comparing its novel anticoagulant agent tecarfarin (previously ATI-5923) with the leading oral anticoagulant warfarin.
ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin
Published July 7, 2009, 7:00 pm, Business Wire via Yahoo! Finance
FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, today announced results from its Phase 2/3 clinical trial, EmbraceAC, comparing its novel anticoagulant agent tecarfarin with the leading oral anticoagulant warfarin.
Have Your Browser Do All the Work
Published July 7, 2009, 9:02 am, GenomeWeb News
To make your browsing experience even better, Bitesize Bio's Nick Oswald names the top 10 Firefox add-ons for scientists that have surfaced since his original 2007 list.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |